Subject to clearances, the five projects are planned for September this year. The UK is contributing four million pounds from the UK Research and Innovation Fund for International Collaboration, and India is matching this with its own resources. In total, eight million pounds will be used to fund the research, said the statement.
Ahmad said, "The UK has already partnered with India's Serum Institute to manufacture the vaccine for COVID-19, if clinical trials are successful, with plans to distribute to a billion people across the developing world. But there is more we can do together to tackle urgent global health issues in the world. Our thriving research and innovation partnerships will benefit people in the UK and India, and beyond."
Sir Philip Barton, High Commissioner to India, said, "The UK is India's second-biggest research partner, with joint research expected to be worth 400 million pounds by next year. This huge investment enables us to work closely together on global health challenges such as the search for a COVID-19 vaccine."
"Today's announcement is another demonstration of our excellent research relationship and will strengthen the important fight against anti-microbial resistance," he added.
Ahmad will chair a virtual roundtable with senior Indian and UK-based stakeholders on cold-chain technologies that are critical for the effective transport of vaccines, ensuring they successfully reach their final destination, according to the statement.
Other elements of the minister's visit include meeting with Minister of State for External Affairs and Parliamentary Affairs, V Muraleedharan, to discuss a number of subjects including multilateral cooperation, a meeting with Gujarat Chief Minister Vijay Rupani, discussions with regional governments and others on opportunities in wind power and a virtual tour of a UK funded solar plant in Rajasthan.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.